5,7-Dichlorokynurenic acid
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
5,7-dichloro-4-oxo-1H-quinoline-2-carboxylic acid
|
|
Identifiers | |
131123-76-7 | |
3D model (Jmol) | Interactive image |
ChemSpider | 1714 |
2361 | |
PubChem | 1779 |
|
|
|
|
Properties | |
C10H5Cl2NO3 | |
Molar mass | 258.05 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
5,7-Dichlorokynurenic acid (DCKA) is a selective NMDA receptor antagonist acting at the glycine site of the NMDA receptor complex.[1]
See also[edit]
References[edit]
- ^ McNamara D, Smith EC, Calligaro DO, O'Malley PJ, McQuaid LA, Dingledine R. 5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors. Neuroscience Letters. 1990 Nov 27;120(1):17-20. PMID 2149877
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |